home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Events -> Courses and Workshops  

Transdermal Drug Delivery

  April 26, 2011  
CfPA - The Center for Professional Advancement, New Brunswick, NJ
October 12-13, 2011

Who Should Attend
This course is intended for individuals in pharmaceutical or biotechnology companies that are interested in learning or in updating their knowledge with regards to the skin as a biological organ and a barrier to overcome when delivering drugs to the circulation, challenges and advantages of transdermal drug delivery. The program will be very valuable to professionals in:

  • Research and Development
  • Applications and formulations
  • QC/QA
  • Sales and marketing

This comprehensive, two-day course is designed to providebasic understanding in design and development of transdermal delivery systems. The delivery of drugs applied to the skin into the systemic circulation is a challenge, not only because the skin presents an excellent barrier, but also because it is difficult to control the amount delivered per period of time. Moreover, when overcoming the barrier adverse reactions such as irritation, itch and discomfort may occur. The first day of the course focuses on the skin as a physical and biological barrier and the challenges it possesses in the development of delivery systems that target drugs into the blood circulation. We will also review the possible paths in the skin for the penetration of drugs, advantages and limitations of transdermal systems.

The second day focuses on methods to measure and evaluate skin absorption and the adverse effects to the skin that result from the patch application.

Organized by: CfPA - The Center for Professional Advancement
Invited Speakers: Nava Dayan, Ph.D.; Skin Care Research Expert

Dr. Dayan earned her Ph.D. in Pharmaceutics from the Hebrew University in Jerusalem specializing in skin delivery. She is currently an Associate Adjunct Professor in the Ernest Mario School of Pharmacy at Rutgers University., and the Research and Development and Safety Assessment Director at Lipo Chemicals Inc. During her 24 years of experience she has specialized in a variety of areas related to skin treatment:

  • The research and understanding of the interaction between topically applied 
    compounds and the skin
  • Findings in skin biochemistry and especially the upper layer of the skin–
    the stratum corneum
  • Delivery of active compounds into and through the skin and the development of delivery 
    systems to facilitate transport, improve bio-availability and reduce toxicity
  • Design and development of topically applied formulations
  • Design of clinical studies to substantiate market claims and to assure safety
  • Academic teaching and lecturing
  • Industrial experience in both development of active compounds, delivery systems and 
    finished formulations
  • Skin absorption studies in vivo and in vitro for safety/efficacy assessment
  • In vitro methodologies for safety assessment of topically applied compounds

Dr. Dayan has received numerous awards of excellence for various papers she has authored. She is the author and coauthor more then 150 publications including book chapters and was granted 8 patents. She is also the editor of the “Skin Aging Hand Book” published by Elsevier; “Innate Immunity of Skin and Oral Mucosa” Book co-edited with Prof. Philip Wertz, “Formulating Skin Care with Natural Products” Book co-edited with Dr. Lambros Kromidas; both published by Wiley and sons. Dr. Dayan is a member of the Dermatopharmaceutics Focus Group, and the Abstract Review Committee for the American Association of Pharmaceutical Scientists (AAPS). She is serves as the Educational Chair of the NYSCC Chapter and on the Scientific Advisory Board of Health Beauty America Expo and the Center for Dermal Research at the Center for Biomaterials. Dr. Dayan teaches at Rutgers University and is the Director of a variety of courses at the Center for Professional Advancement.
Deadline for Abstracts: n/a
Registration: Please click here for registration information.
E-mail: sberg@cfpa.com
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.